Brief: Dextech Medical AB First Results From Dextech's Phase Iib Study For Osteodex
Dextech Medical AB DEXTECH.TE :
* FIRST RESULTS FROM DEXTECH'S PHASE IIB STUDY FOR OSTEODEX
* SAYS NO SERIOUS ADVERSE EVENTS WERE NOTED
* SAYS RESULTS MEET PRIMARY OBJECTIVE
Source text for Eikon: ID:nWkrb2mYVM
Further company coverage: DEXTECH.TE
Recent news on Dextech Medical AB
See all newsSwedish drug developer DexTech's Q4 operating loss widens; reports positive patient outcomes
Brief: DexTech Q4 Operating Profit SEK -1.9 Million
Sweden's DexTech Q3 loss widens, OsteoDex drug study shows favorable safety profile
Brief: DexTech Q3 Operating Profit SEK -1.7 Million
Brief: DexTech Q4 Operating Profit SEK -1.6 Million